OB/GYN Clinical Alert – January 1, 2020
January 1, 2020
View Issues
-
News From the WHI: Soft Drink Consumption and Bone Health
Participants from the Women’s Health Initiative study who reported consumption of more than two soft drinks per day showed a higher incidence of hip fracture compared to those consuming no soft drinks.
-
Influenza and Pertussis Vaccines for Pregnant Women: Are We Doing Enough to Encourage Vaccination?
In this cross-sectional analysis, pregnant women disproportionately accounted for 24-34% of influenza-associated hospitalizations among women aged 15 to 44 years, and infants younger than 2 months of age comprised the highest proportion of pertussis deaths. The reasons why pregnant women did not elect recommended immunizations included not believing they were effective, not knowing they should receive Tdap every pregnancy, and being concerned that the vaccines would harm the fetus.
-
PARP Inhibitors: An Adjunct to Initial Standard Treatment for Advanced Ovarian Cancer Patients
The PRIMA study is a randomized, double-blind, multi-institutional, international phase 3 trial testing the PARP inhibitor niraparib against placebo after first-line standard treatment with platinum-based chemotherapy for newly diagnosed ovarian cancer.
-
The Affordable Care Act: Progress in Reducing the Rate of Unintended Pregnancy
Data from the latest release of the National Survey of Family Growth supports that the contraception coverage mandate of the Affordable Care Act has resulted in a decrease in the incidence of unintended pregnancy, particularly among women with government coverage.